Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Adjuvant radiotherapy for extremity and trunk wall atypical lipomatous tumor/well-differentiated LPS (ALT/WD-LPS): a French Sarcoma Group (GSF-GETO) study.
[well-differentiated liposarcoma]
The
role
of
adjuvant
radiotherapy
(
RT
)
in
the
management
of
atypical
lipomatous
tumor
/
well-differentiated
liposarcoma
(
ALT
/
WD-LPS
)
remains
controversial
.
Two
hundred
eighty-
three
patients
with
operable
ALT
/
WD-LPS
,
no
history
of
previous
cancer
,
chemotherapy
(
CT
)
or
RT
,
treated
between
1984
and
2011
registered
in
the
Conticabase
database
were
included
and
described
.
Overall
(
OS
)
,
progression-free
survival
(
PFS
)
and
time
to
local
relapse
(
TTLR
)
were
evaluated
from
the
time
of
first
treatment
.
Three
of
20
centers
enrolled
58
%
of
the
patients
.
Median
age
at
diagnosis
was
61
(
range
25
-
94
)
years
,
147
patients
(
52
%
)
were
males
,
222
(
78
%
)
patients
had
their
primary
tumor
located
in
an
extremity
while
36
(
13
%
)
and
25
(
9
%
)
had
tumors
involving
the
girdle
and
the
trunk
wall
,
respectively
.
The
median
size
of
primary
tumors
was
17
cm
(
range
2
-
48
cm
)
.
Adjuvant
RT
was
given
to
132
patients
(
47
%
)
.
Patients
who
received
adjuvant
RT
had
larger
tumors
(
P
=
0
.
005
)
,
involving
more
often
the
distal
limbs
(
P
<
0
.
001
)
.
Use
of
adjuvant
RT
varied
across
centers
and
along
the
study
period
.
Other
characteristics
were
balanced
between
the
two
groups
.
Median
follow-up
was
61
.
7
months
.
None
of
the
patients
developed
metastasis
during
follow-up
.
The
5
-
year
local
relapse-free
survival
rates
were
98
.
3
%
versus
80
.
3
%
with
and
without
adjuvant
RT
,
respectively
(
P
<
0
.
001
)
.
Once
stratified
on
time
period
(
before
/
after
2003
)
,
adjuvant
RT
,
tumor
site
and
margin
status
(
R
0
versus
other
)
were
independently
associated
with
TTLR
.
No
OS
difference
was
observed
(
P
=
0
.
105
)
.
In
this
study
,
adjuvant
RT
following
resection
of
ALT
/
WD-LPS
was
associated
with
a
reduction
of
LR
risk
.
Diseases
Validation
Diseases presenting
"tumor site"
symptom
esophageal carcinoma
liposarcoma
pleomorphic liposarcoma
severe combined immunodeficiency
well-differentiated liposarcoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom